Investigating how HIV-1 affects RNA modifications in immune cells
HIV-1-induced upregulation of m6A modifications of cellular RNA in CD4+ T-cells
['FUNDING_R21'] · UNIVERSITY OF IOWA · NIH-10668515
This study is looking at how the HIV-1 virus changes the way RNA works in immune cells called CD4+ T cells, focusing on a specific HIV protein that might help the virus grow, and it aims to find out how these changes affect the immune response, which could lead to better understanding and treatment of HIV.
Quick facts
| Phase | ['FUNDING_R21'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF IOWA (nih funded) |
| Locations | 1 site (IOWA CITY, UNITED STATES) |
| Trial ID | NIH-10668515 on ClinicalTrials.gov |
What this research studies
This research explores how the HIV-1 virus alters the chemical modifications of RNA in CD4+ T cells, which are crucial for immune response. The team will examine the role of a specific HIV protein, gp120, in increasing these modifications, potentially impacting how the virus replicates. By using advanced techniques and interdisciplinary collaboration, the study aims to uncover the mechanisms behind these changes and their effects on cellular function. This could lead to new insights into HIV infection and immune regulation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who have active CD4+ T cell involvement.
Not a fit: Patients who are not infected with HIV or have a different type of immune deficiency may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment strategies for HIV infection.
How similar studies have performed: While the specific approach of examining m6A modifications in the context of HIV is novel, related research has shown promise in understanding viral interactions with host cellular mechanisms.
Where this research is happening
IOWA CITY, UNITED STATES
- UNIVERSITY OF IOWA — IOWA CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: WU, LI — UNIVERSITY OF IOWA
- Study coordinator: WU, LI
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.